nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLC22A2—Cladribine—multiple sclerosis	0.0653	0.0942	CbGbCtD
Quinidine—SLC22A1—Cladribine—multiple sclerosis	0.0567	0.0819	CbGbCtD
Quinidine—CYP2E1—Fingolimod—multiple sclerosis	0.0533	0.077	CbGbCtD
Quinidine—SLCO1A2—Prednisolone—multiple sclerosis	0.0412	0.0595	CbGbCtD
Quinidine—SLCO1A2—Prednisone—multiple sclerosis	0.0389	0.0562	CbGbCtD
Quinidine—ABCB11—Dexamethasone—multiple sclerosis	0.0383	0.0553	CbGbCtD
Quinidine—CYP2D6—Fingolimod—multiple sclerosis	0.0254	0.0367	CbGbCtD
Quinidine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0251	0.0362	CbGbCtD
Quinidine—SLCO1A2—Dexamethasone—multiple sclerosis	0.0243	0.0351	CbGbCtD
Quinidine—ABCC2—Dexamethasone—multiple sclerosis	0.0202	0.0291	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—multiple sclerosis	0.0195	0.0282	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—multiple sclerosis	0.0184	0.0266	CbGbCtD
Quinidine—ABCB1—Methylprednisolone—multiple sclerosis	0.0174	0.0251	CbGbCtD
Quinidine—SLC22A8—Methotrexate—multiple sclerosis	0.017	0.0246	CbGbCtD
Quinidine—CYP1A1—Dexamethasone—multiple sclerosis	0.0168	0.0243	CbGbCtD
Quinidine—ABCC2—Methotrexate—multiple sclerosis	0.0162	0.0234	CbGbCtD
Quinidine—CYP3A4—Fingolimod—multiple sclerosis	0.0162	0.0233	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0135	0.0194	CbGbCtD
Quinidine—CYP3A7—Dexamethasone—multiple sclerosis	0.0135	0.0194	CbGbCtD
Quinidine—CYP2E1—Dexamethasone—multiple sclerosis	0.013	0.0188	CbGbCtD
Quinidine—CYP2B6—Dexamethasone—multiple sclerosis	0.0128	0.0185	CbGbCtD
Quinidine—ABCB1—Mitoxantrone—multiple sclerosis	0.0127	0.0183	CbGbCtD
Quinidine—SCN3A—spinal nerve—multiple sclerosis	0.0124	0.193	CbGeAlD
Quinidine—ABCB1—Betamethasone—multiple sclerosis	0.0113	0.0163	CbGbCtD
Quinidine—ABCB1—Prednisolone—multiple sclerosis	0.0111	0.0161	CbGbCtD
Quinidine—ABCB1—Prednisone—multiple sclerosis	0.0105	0.0152	CbGbCtD
Quinidine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0104	0.015	CbGbCtD
Quinidine—CYP2C8—Dexamethasone—multiple sclerosis	0.00971	0.014	CbGbCtD
Quinidine—CYP3A4—Triamcinolone—multiple sclerosis	0.00789	0.0114	CbGbCtD
Quinidine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00759	0.011	CbGbCtD
Quinidine—CYP2C9—Dexamethasone—multiple sclerosis	0.00677	0.00977	CbGbCtD
Quinidine—CYP3A4—Betamethasone—multiple sclerosis	0.00677	0.00977	CbGbCtD
Quinidine—CYP3A4—Prednisolone—multiple sclerosis	0.00668	0.00964	CbGbCtD
Quinidine—ABCB1—Dexamethasone—multiple sclerosis	0.00657	0.00948	CbGbCtD
Quinidine—CYP3A4—Prednisone—multiple sclerosis	0.00631	0.0091	CbGbCtD
Quinidine—CYP2D6—Dexamethasone—multiple sclerosis	0.00619	0.00894	CbGbCtD
Quinidine—ABCB1—Methotrexate—multiple sclerosis	0.00528	0.00762	CbGbCtD
Quinidine—CYP3A4—Dexamethasone—multiple sclerosis	0.00394	0.00568	CbGbCtD
Quinidine—KCNK6—nervous system—multiple sclerosis	0.00203	0.0316	CbGeAlD
Quinidine—KCNK6—central nervous system—multiple sclerosis	0.00195	0.0304	CbGeAlD
Quinidine—KCNK1—brainstem—multiple sclerosis	0.00172	0.0267	CbGeAlD
Quinidine—KCNK6—brain—multiple sclerosis	0.00155	0.0241	CbGeAlD
Quinidine—SCN1A—brainstem—multiple sclerosis	0.00128	0.0198	CbGeAlD
Quinidine—KCNK1—medulla oblongata—multiple sclerosis	0.0012	0.0186	CbGeAlD
Quinidine—SCN2A—brainstem—multiple sclerosis	0.00117	0.0182	CbGeAlD
Quinidine—KCNK1—midbrain—multiple sclerosis	0.00109	0.017	CbGeAlD
Quinidine—KCNK1—spinal cord—multiple sclerosis	0.00107	0.0166	CbGeAlD
Quinidine—KCNK1—nervous system—multiple sclerosis	0.0009	0.014	CbGeAlD
Quinidine—SCN1A—medulla oblongata—multiple sclerosis	0.000889	0.0138	CbGeAlD
Quinidine—KCNK1—central nervous system—multiple sclerosis	0.000866	0.0135	CbGeAlD
Quinidine—KCNK1—cerebellum—multiple sclerosis	0.000847	0.0132	CbGeAlD
Quinidine—SCN2A—medulla oblongata—multiple sclerosis	0.000816	0.0127	CbGeAlD
Quinidine—SCN1A—midbrain—multiple sclerosis	0.000813	0.0126	CbGeAlD
Quinidine—SCN1A—spinal cord—multiple sclerosis	0.000793	0.0123	CbGeAlD
Quinidine—SCN2A—midbrain—multiple sclerosis	0.000746	0.0116	CbGeAlD
Quinidine—SCN2A—spinal cord—multiple sclerosis	0.000728	0.0113	CbGeAlD
Quinidine—SCN3A—medulla oblongata—multiple sclerosis	0.000717	0.0111	CbGeAlD
Quinidine—KCNK1—brain—multiple sclerosis	0.000688	0.0107	CbGeAlD
Quinidine—SCN1A—nervous system—multiple sclerosis	0.000668	0.0104	CbGeAlD
Quinidine—SCN3A—midbrain—multiple sclerosis	0.000655	0.0102	CbGeAlD
Quinidine—SCN1A—central nervous system—multiple sclerosis	0.000643	0.01	CbGeAlD
Quinidine—SCN3A—spinal cord—multiple sclerosis	0.000639	0.00994	CbGeAlD
Quinidine—SCN1A—cerebellum—multiple sclerosis	0.000629	0.00977	CbGeAlD
Quinidine—SCN2A—nervous system—multiple sclerosis	0.000613	0.00953	CbGeAlD
Quinidine—SCN2A—central nervous system—multiple sclerosis	0.00059	0.00917	CbGeAlD
Quinidine—ORM1—spinal cord—multiple sclerosis	0.000582	0.00905	CbGeAlD
Quinidine—SCN2A—cerebellum—multiple sclerosis	0.000577	0.00897	CbGeAlD
Quinidine—SLCO1A2—medulla oblongata—multiple sclerosis	0.000576	0.00895	CbGeAlD
Quinidine—SLC22A5—retina—multiple sclerosis	0.000575	0.00894	CbGeAlD
Quinidine—SLC22A4—spinal cord—multiple sclerosis	0.00056	0.0087	CbGeAlD
Quinidine—SCN3A—nervous system—multiple sclerosis	0.000539	0.00838	CbGeAlD
Quinidine—SCN5A—nervous system—multiple sclerosis	0.000537	0.00835	CbGeAlD
Quinidine—SLCO1A2—midbrain—multiple sclerosis	0.000526	0.00818	CbGeAlD
Quinidine—SCN3A—central nervous system—multiple sclerosis	0.000519	0.00806	CbGeAlD
Quinidine—SCN5A—central nervous system—multiple sclerosis	0.000517	0.00804	CbGeAlD
Quinidine—SLCO1A2—spinal cord—multiple sclerosis	0.000513	0.00798	CbGeAlD
Quinidine—SCN1A—brain—multiple sclerosis	0.000511	0.00794	CbGeAlD
Quinidine—SCN3A—cerebellum—multiple sclerosis	0.000507	0.00788	CbGeAlD
Quinidine—ORM1—nervous system—multiple sclerosis	0.00049	0.00762	CbGeAlD
Quinidine—ORM1—central nervous system—multiple sclerosis	0.000472	0.00734	CbGeAlD
Quinidine—SCN2A—brain—multiple sclerosis	0.000469	0.00728	CbGeAlD
Quinidine—CHRM2—nervous system—multiple sclerosis	0.000457	0.00711	CbGeAlD
Quinidine—SLC22A1—nervous system—multiple sclerosis	0.000449	0.00698	CbGeAlD
Quinidine—SLC22A4—cerebellum—multiple sclerosis	0.000444	0.0069	CbGeAlD
Quinidine—CHRM2—central nervous system—multiple sclerosis	0.00044	0.00684	CbGeAlD
Quinidine—KCNH2—medulla oblongata—multiple sclerosis	0.00044	0.00683	CbGeAlD
Quinidine—SLCO1A2—nervous system—multiple sclerosis	0.000433	0.00672	CbGeAlD
Quinidine—SLC22A1—central nervous system—multiple sclerosis	0.000433	0.00672	CbGeAlD
Quinidine—SLCO1A2—central nervous system—multiple sclerosis	0.000417	0.00647	CbGeAlD
Quinidine—SLC22A5—medulla oblongata—multiple sclerosis	0.000416	0.00646	CbGeAlD
Quinidine—SLC22A8—nervous system—multiple sclerosis	0.000413	0.00642	CbGeAlD
Quinidine—SCN3A—brain—multiple sclerosis	0.000412	0.0064	CbGeAlD
Quinidine—SCN5A—brain—multiple sclerosis	0.000411	0.00638	CbGeAlD
Quinidine—SLCO1A2—cerebellum—multiple sclerosis	0.000407	0.00633	CbGeAlD
Quinidine—KCNH2—midbrain—multiple sclerosis	0.000402	0.00625	CbGeAlD
Quinidine—SLC22A8—central nervous system—multiple sclerosis	0.000398	0.00618	CbGeAlD
Quinidine—KCNH2—spinal cord—multiple sclerosis	0.000392	0.00609	CbGeAlD
Quinidine—CYP2D6—brainstem—multiple sclerosis	0.000385	0.00598	CbGeAlD
Quinidine—SLC22A5—midbrain—multiple sclerosis	0.00038	0.0059	CbGeAlD
Quinidine—SLC22A5—spinal cord—multiple sclerosis	0.000371	0.00576	CbGeAlD
Quinidine—SLC22A4—brain—multiple sclerosis	0.000361	0.00561	CbGeAlD
Quinidine—CHRM2—brain—multiple sclerosis	0.00035	0.00543	CbGeAlD
Quinidine—SLC22A1—brain—multiple sclerosis	0.000343	0.00534	CbGeAlD
Quinidine—CYP2E1—medulla oblongata—multiple sclerosis	0.000339	0.00526	CbGeAlD
Quinidine—SLCO1A2—brain—multiple sclerosis	0.000331	0.00514	CbGeAlD
Quinidine—KCNH2—nervous system—multiple sclerosis	0.00033	0.00514	CbGeAlD
Quinidine—KCNH2—central nervous system—multiple sclerosis	0.000318	0.00494	CbGeAlD
Quinidine—SLC22A8—brain—multiple sclerosis	0.000316	0.00491	CbGeAlD
Quinidine—KCNH2—cerebellum—multiple sclerosis	0.000311	0.00483	CbGeAlD
Quinidine—CYP2E1—spinal cord—multiple sclerosis	0.000302	0.00469	CbGeAlD
Quinidine—SLC22A5—cerebellum—multiple sclerosis	0.000294	0.00457	CbGeAlD
Quinidine—CYP1A1—nervous system—multiple sclerosis	0.000279	0.00434	CbGeAlD
Quinidine—CYP2B6—nervous system—multiple sclerosis	0.000271	0.00421	CbGeAlD
Quinidine—CYP1A1—central nervous system—multiple sclerosis	0.000269	0.00418	CbGeAlD
Quinidine—ABCB1—retina—multiple sclerosis	0.000267	0.00415	CbGeAlD
Quinidine—CYP2B6—central nervous system—multiple sclerosis	0.000261	0.00406	CbGeAlD
Quinidine—CYP2E1—nervous system—multiple sclerosis	0.000254	0.00395	CbGeAlD
Quinidine—KCNH2—brain—multiple sclerosis	0.000253	0.00393	CbGeAlD
Quinidine—CYP2E1—central nervous system—multiple sclerosis	0.000245	0.00381	CbGeAlD
Quinidine—CYP2E1—cerebellum—multiple sclerosis	0.000239	0.00372	CbGeAlD
Quinidine—SLC22A5—brain—multiple sclerosis	0.000239	0.00371	CbGeAlD
Quinidine—CYP2C8—brain—multiple sclerosis	0.000231	0.00359	CbGeAlD
Quinidine—CYP1A1—brain—multiple sclerosis	0.000213	0.00331	CbGeAlD
Quinidine—CYP2B6—brain—multiple sclerosis	0.000207	0.00322	CbGeAlD
Quinidine—CYP3A4—nervous system—multiple sclerosis	0.000205	0.00318	CbGeAlD
Quinidine—CYP2D6—nervous system—multiple sclerosis	0.000201	0.00313	CbGeAlD
Quinidine—CYP3A4—central nervous system—multiple sclerosis	0.000197	0.00306	CbGeAlD
Quinidine—CYP2E1—brain—multiple sclerosis	0.000194	0.00302	CbGeAlD
Quinidine—Asthma—Methotrexate—multiple sclerosis	0.000194	0.00124	CcSEcCtD
Quinidine—CYP2D6—central nervous system—multiple sclerosis	0.000194	0.00301	CbGeAlD
Quinidine—Convulsion—Prednisolone—multiple sclerosis	0.000193	0.00123	CcSEcCtD
Quinidine—ABCB1—medulla oblongata—multiple sclerosis	0.000193	0.003	CbGeAlD
Quinidine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000193	0.00123	CcSEcCtD
Quinidine—CYP2D6—cerebellum—multiple sclerosis	0.00019	0.00295	CbGeAlD
Quinidine—Bradycardia—Prednisone—multiple sclerosis	0.000189	0.00121	CcSEcCtD
Quinidine—Diarrhoea—Azathioprine—multiple sclerosis	0.000187	0.00119	CcSEcCtD
Quinidine—Angioedema—Triamcinolone—multiple sclerosis	0.000187	0.00119	CcSEcCtD
Quinidine—Haemoglobin—Prednisone—multiple sclerosis	0.000187	0.00119	CcSEcCtD
Quinidine—Angioedema—Methylprednisolone—multiple sclerosis	0.000187	0.00119	CcSEcCtD
Quinidine—Haemorrhage—Prednisone—multiple sclerosis	0.000186	0.00118	CcSEcCtD
Quinidine—Erythema—Dexamethasone—multiple sclerosis	0.000186	0.00118	CcSEcCtD
Quinidine—Erythema—Betamethasone—multiple sclerosis	0.000186	0.00118	CcSEcCtD
Quinidine—Pancytopenia—Methotrexate—multiple sclerosis	0.000184	0.00117	CcSEcCtD
Quinidine—Vertigo—Triamcinolone—multiple sclerosis	0.000184	0.00117	CcSEcCtD
Quinidine—Syncope—Triamcinolone—multiple sclerosis	0.000184	0.00117	CcSEcCtD
Quinidine—Vertigo—Methylprednisolone—multiple sclerosis	0.000184	0.00117	CcSEcCtD
Quinidine—Syncope—Methylprednisolone—multiple sclerosis	0.000183	0.00117	CcSEcCtD
Quinidine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000183	0.00116	CcSEcCtD
Quinidine—Oedema—Prednisolone—multiple sclerosis	0.000182	0.00116	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—multiple sclerosis	0.000181	0.00116	CcSEcCtD
Quinidine—Dizziness—Azathioprine—multiple sclerosis	0.000181	0.00115	CcSEcCtD
Quinidine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000181	0.00115	CcSEcCtD
Quinidine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00018	0.00115	CcSEcCtD
Quinidine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00018	0.00114	CcSEcCtD
Quinidine—Shock—Prednisolone—multiple sclerosis	0.000179	0.00114	CcSEcCtD
Quinidine—Convulsion—Triamcinolone—multiple sclerosis	0.000177	0.00113	CcSEcCtD
Quinidine—Tachycardia—Prednisolone—multiple sclerosis	0.000177	0.00113	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000177	0.00113	CcSEcCtD
Quinidine—Convulsion—Methylprednisolone—multiple sclerosis	0.000177	0.00113	CcSEcCtD
Quinidine—ABCB1—midbrain—multiple sclerosis	0.000176	0.00274	CbGeAlD
Quinidine—Urticaria—Mitoxantrone—multiple sclerosis	0.000176	0.00112	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000176	0.00112	CcSEcCtD
Quinidine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000175	0.00112	CcSEcCtD
Quinidine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000175	0.00112	CcSEcCtD
Quinidine—Myalgia—Triamcinolone—multiple sclerosis	0.000174	0.00111	CcSEcCtD
Quinidine—Vomiting—Azathioprine—multiple sclerosis	0.000174	0.00111	CcSEcCtD
Quinidine—Myalgia—Methylprednisolone—multiple sclerosis	0.000174	0.00111	CcSEcCtD
Quinidine—Eye disorder—Prednisone—multiple sclerosis	0.000174	0.00111	CcSEcCtD
Quinidine—Rash—Azathioprine—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Quinidine—Dermatitis—Azathioprine—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Quinidine—Flushing—Prednisone—multiple sclerosis	0.000172	0.0011	CcSEcCtD
Quinidine—ABCB1—spinal cord—multiple sclerosis	0.000172	0.00267	CbGeAlD
Quinidine—Headache—Azathioprine—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000172	0.00109	CcSEcCtD
Quinidine—Renal failure—Methotrexate—multiple sclerosis	0.00017	0.00108	CcSEcCtD
Quinidine—Angioedema—Dexamethasone—multiple sclerosis	0.00017	0.00108	CcSEcCtD
Quinidine—Angioedema—Betamethasone—multiple sclerosis	0.00017	0.00108	CcSEcCtD
Quinidine—Confusional state—Methylprednisolone—multiple sclerosis	0.000168	0.00107	CcSEcCtD
Quinidine—Immune system disorder—Prednisone—multiple sclerosis	0.000168	0.00107	CcSEcCtD
Quinidine—Oedema—Triamcinolone—multiple sclerosis	0.000167	0.00106	CcSEcCtD
Quinidine—Vertigo—Betamethasone—multiple sclerosis	0.000167	0.00106	CcSEcCtD
Quinidine—Vertigo—Dexamethasone—multiple sclerosis	0.000167	0.00106	CcSEcCtD
Quinidine—Syncope—Betamethasone—multiple sclerosis	0.000167	0.00106	CcSEcCtD
Quinidine—Syncope—Dexamethasone—multiple sclerosis	0.000167	0.00106	CcSEcCtD
Quinidine—Sweating—Methotrexate—multiple sclerosis	0.000166	0.00106	CcSEcCtD
Quinidine—Shock—Triamcinolone—multiple sclerosis	0.000164	0.00105	CcSEcCtD
Quinidine—Shock—Methylprednisolone—multiple sclerosis	0.000164	0.00104	CcSEcCtD
Quinidine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000164	0.00104	CcSEcCtD
Quinidine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000163	0.00104	CcSEcCtD
Quinidine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000163	0.00104	CcSEcCtD
Quinidine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000163	0.00104	CcSEcCtD
Quinidine—Tachycardia—Triamcinolone—multiple sclerosis	0.000163	0.00104	CcSEcCtD
Quinidine—Mental disorder—Prednisone—multiple sclerosis	0.000163	0.00104	CcSEcCtD
Quinidine—Nausea—Azathioprine—multiple sclerosis	0.000163	0.00104	CcSEcCtD
Quinidine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000163	0.00104	CcSEcCtD
Quinidine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000162	0.00103	CcSEcCtD
Quinidine—Erythema—Prednisone—multiple sclerosis	0.000162	0.00103	CcSEcCtD
Quinidine—Malnutrition—Prednisone—multiple sclerosis	0.000162	0.00103	CcSEcCtD
Quinidine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000162	0.00103	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000161	0.00103	CcSEcCtD
Quinidine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000161	0.00103	CcSEcCtD
Quinidine—Convulsion—Betamethasone—multiple sclerosis	0.000161	0.00103	CcSEcCtD
Quinidine—Convulsion—Dexamethasone—multiple sclerosis	0.000161	0.00103	CcSEcCtD
Quinidine—Asthenia—Mitoxantrone—multiple sclerosis	0.000159	0.00101	CcSEcCtD
Quinidine—Myalgia—Dexamethasone—multiple sclerosis	0.000158	0.00101	CcSEcCtD
Quinidine—Myalgia—Betamethasone—multiple sclerosis	0.000158	0.00101	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—multiple sclerosis	0.000156	0.000994	CcSEcCtD
Quinidine—Hypotension—Methylprednisolone—multiple sclerosis	0.000156	0.000992	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—multiple sclerosis	0.000155	0.000989	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—multiple sclerosis	0.000155	0.000989	CcSEcCtD
Quinidine—CYP2D6—brain—multiple sclerosis	0.000154	0.00239	CbGeAlD
Quinidine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000153	0.000977	CcSEcCtD
Quinidine—Vision blurred—Prednisone—multiple sclerosis	0.000152	0.000971	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—multiple sclerosis	0.000152	0.00097	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000152	0.00097	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000152	0.000968	CcSEcCtD
Quinidine—Oedema—Dexamethasone—multiple sclerosis	0.000152	0.000966	CcSEcCtD
Quinidine—Oedema—Betamethasone—multiple sclerosis	0.000152	0.000966	CcSEcCtD
Quinidine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000152	0.000965	CcSEcCtD
Quinidine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00015	0.000954	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—multiple sclerosis	0.00015	0.000954	CcSEcCtD
Quinidine—Shock—Betamethasone—multiple sclerosis	0.000149	0.00095	CcSEcCtD
Quinidine—Shock—Dexamethasone—multiple sclerosis	0.000149	0.00095	CcSEcCtD
Quinidine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000149	0.000949	CcSEcCtD
Quinidine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000149	0.000947	CcSEcCtD
Quinidine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000149	0.000947	CcSEcCtD
Quinidine—Agitation—Prednisone—multiple sclerosis	0.000149	0.000947	CcSEcCtD
Quinidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000148	0.000946	CcSEcCtD
Quinidine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000148	0.000946	CcSEcCtD
Quinidine—Tachycardia—Dexamethasone—multiple sclerosis	0.000148	0.000943	CcSEcCtD
Quinidine—Tachycardia—Betamethasone—multiple sclerosis	0.000148	0.000943	CcSEcCtD
Quinidine—Angioedema—Prednisone—multiple sclerosis	0.000148	0.000942	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000147	0.000936	CcSEcCtD
Quinidine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000147	0.000934	CcSEcCtD
Quinidine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000147	0.000934	CcSEcCtD
Quinidine—Vertigo—Prednisone—multiple sclerosis	0.000145	0.000926	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—multiple sclerosis	0.000145	0.000925	CcSEcCtD
Quinidine—Syncope—Prednisone—multiple sclerosis	0.000145	0.000924	CcSEcCtD
Quinidine—ABCB1—nervous system—multiple sclerosis	0.000145	0.00225	CbGeAlD
Quinidine—Tinnitus—Methotrexate—multiple sclerosis	0.000145	0.000923	CcSEcCtD
Quinidine—Anorexia—Betamethasone—multiple sclerosis	0.000145	0.000921	CcSEcCtD
Quinidine—Anorexia—Dexamethasone—multiple sclerosis	0.000145	0.000921	CcSEcCtD
Quinidine—Urticaria—Prednisolone—multiple sclerosis	0.000144	0.00092	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000144	0.000918	CcSEcCtD
Quinidine—Loss of consciousness—Prednisone—multiple sclerosis	0.000142	0.000906	CcSEcCtD
Quinidine—Hypotension—Dexamethasone—multiple sclerosis	0.000142	0.000903	CcSEcCtD
Quinidine—Hypotension—Betamethasone—multiple sclerosis	0.000142	0.000903	CcSEcCtD
Quinidine—Vomiting—Mitoxantrone—multiple sclerosis	0.000141	0.000897	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—multiple sclerosis	0.00014	0.000894	CcSEcCtD
Quinidine—Convulsion—Prednisone—multiple sclerosis	0.00014	0.000893	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00014	0.000892	CcSEcCtD
Quinidine—Rash—Mitoxantrone—multiple sclerosis	0.00014	0.00089	CcSEcCtD
Quinidine—ABCB1—central nervous system—multiple sclerosis	0.00014	0.00217	CbGeAlD
Quinidine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00014	0.000889	CcSEcCtD
Quinidine—Chills—Methotrexate—multiple sclerosis	0.000139	0.000888	CcSEcCtD
Quinidine—Headache—Mitoxantrone—multiple sclerosis	0.000139	0.000884	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000138	0.00088	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000138	0.00088	CcSEcCtD
Quinidine—Myalgia—Prednisone—multiple sclerosis	0.000138	0.000877	CcSEcCtD
Quinidine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000138	0.000877	CcSEcCtD
Quinidine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000137	0.000875	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000137	0.000871	CcSEcCtD
Quinidine—ABCB1—cerebellum—multiple sclerosis	0.000136	0.00212	CbGeAlD
Quinidine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000136	0.000869	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—multiple sclerosis	0.000136	0.000867	CcSEcCtD
Quinidine—Erythema—Methotrexate—multiple sclerosis	0.000135	0.000861	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—multiple sclerosis	0.000135	0.000861	CcSEcCtD
Quinidine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000134	0.000853	CcSEcCtD
Quinidine—Urticaria—Triamcinolone—multiple sclerosis	0.000133	0.000846	CcSEcCtD
Quinidine—Urticaria—Methylprednisolone—multiple sclerosis	0.000132	0.000844	CcSEcCtD
Quinidine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000132	0.000841	CcSEcCtD
Quinidine—Oedema—Prednisone—multiple sclerosis	0.000132	0.000841	CcSEcCtD
Quinidine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000132	0.00084	CcSEcCtD
Quinidine—Decreased appetite—Betamethasone—multiple sclerosis	0.000132	0.00084	CcSEcCtD
Quinidine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000132	0.00084	CcSEcCtD
Quinidine—Nausea—Mitoxantrone—multiple sclerosis	0.000132	0.000838	CcSEcCtD
Quinidine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000131	0.000834	CcSEcCtD
Quinidine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000131	0.000834	CcSEcCtD
Quinidine—Shock—Prednisone—multiple sclerosis	0.00013	0.000828	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—multiple sclerosis	0.000129	0.000825	CcSEcCtD
Quinidine—Tachycardia—Prednisone—multiple sclerosis	0.000129	0.000821	CcSEcCtD
Quinidine—Skin disorder—Prednisone—multiple sclerosis	0.000128	0.000817	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000128	0.000813	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—multiple sclerosis	0.000127	0.000812	CcSEcCtD
Quinidine—Anorexia—Prednisone—multiple sclerosis	0.000126	0.000802	CcSEcCtD
Quinidine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000125	0.000796	CcSEcCtD
Quinidine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000125	0.000796	CcSEcCtD
Quinidine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000124	0.00079	CcSEcCtD
Quinidine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000124	0.00079	CcSEcCtD
Quinidine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000123	0.000784	CcSEcCtD
Quinidine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000123	0.000783	CcSEcCtD
Quinidine—Vertigo—Methotrexate—multiple sclerosis	0.000121	0.000774	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—multiple sclerosis	0.000121	0.000771	CcSEcCtD
Quinidine—Urticaria—Betamethasone—multiple sclerosis	0.00012	0.000767	CcSEcCtD
Quinidine—Urticaria—Dexamethasone—multiple sclerosis	0.00012	0.000767	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00012	0.000766	CcSEcCtD
Quinidine—Dizziness—Prednisolone—multiple sclerosis	0.00012	0.000765	CcSEcCtD
Quinidine—Asthenia—Triamcinolone—multiple sclerosis	0.00012	0.000764	CcSEcCtD
Quinidine—Abdominal pain—Betamethasone—multiple sclerosis	0.00012	0.000764	CcSEcCtD
Quinidine—Body temperature increased—Betamethasone—multiple sclerosis	0.00012	0.000764	CcSEcCtD
Quinidine—Abdominal pain—Dexamethasone—multiple sclerosis	0.00012	0.000764	CcSEcCtD
Quinidine—Body temperature increased—Dexamethasone—multiple sclerosis	0.00012	0.000764	CcSEcCtD
Quinidine—Asthenia—Methylprednisolone—multiple sclerosis	0.00012	0.000762	CcSEcCtD
Quinidine—Pruritus—Triamcinolone—multiple sclerosis	0.000118	0.000753	CcSEcCtD
Quinidine—Pruritus—Methylprednisolone—multiple sclerosis	0.000118	0.000751	CcSEcCtD
Quinidine—Convulsion—Methotrexate—multiple sclerosis	0.000117	0.000746	CcSEcCtD
Quinidine—Chest pain—Methotrexate—multiple sclerosis	0.000115	0.000733	CcSEcCtD
Quinidine—Myalgia—Methotrexate—multiple sclerosis	0.000115	0.000733	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—multiple sclerosis	0.000115	0.000731	CcSEcCtD
Quinidine—Rash—Prednisolone—multiple sclerosis	0.000115	0.00073	CcSEcCtD
Quinidine—Dermatitis—Prednisolone—multiple sclerosis	0.000114	0.000729	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000114	0.000728	CcSEcCtD
Quinidine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000114	0.000727	CcSEcCtD
Quinidine—Headache—Prednisolone—multiple sclerosis	0.000114	0.000725	CcSEcCtD
Quinidine—Confusional state—Methotrexate—multiple sclerosis	0.000111	0.000709	CcSEcCtD
Quinidine—ABCB1—brain—multiple sclerosis	0.000111	0.00172	CbGeAlD
Quinidine—Dizziness—Triamcinolone—multiple sclerosis	0.000111	0.000704	CcSEcCtD
Quinidine—Dizziness—Methylprednisolone—multiple sclerosis	0.00011	0.000702	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—multiple sclerosis	0.000109	0.000693	CcSEcCtD
Quinidine—Asthenia—Betamethasone—multiple sclerosis	0.000109	0.000693	CcSEcCtD
Quinidine—Asthenia—Dexamethasone—multiple sclerosis	0.000109	0.000693	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000108	0.000689	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000108	0.000688	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000108	0.000688	CcSEcCtD
Quinidine—Nausea—Prednisolone—multiple sclerosis	0.000108	0.000688	CcSEcCtD
Quinidine—Pruritus—Dexamethasone—multiple sclerosis	0.000107	0.000683	CcSEcCtD
Quinidine—Pruritus—Betamethasone—multiple sclerosis	0.000107	0.000683	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—multiple sclerosis	0.000107	0.000683	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000107	0.00068	CcSEcCtD
Quinidine—Vomiting—Triamcinolone—multiple sclerosis	0.000106	0.000677	CcSEcCtD
Quinidine—Vomiting—Methylprednisolone—multiple sclerosis	0.000106	0.000675	CcSEcCtD
Quinidine—Rash—Triamcinolone—multiple sclerosis	0.000105	0.000671	CcSEcCtD
Quinidine—Dermatitis—Triamcinolone—multiple sclerosis	0.000105	0.000671	CcSEcCtD
Quinidine—Anorexia—Methotrexate—multiple sclerosis	0.000105	0.00067	CcSEcCtD
Quinidine—Rash—Methylprednisolone—multiple sclerosis	0.000105	0.00067	CcSEcCtD
Quinidine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000105	0.000669	CcSEcCtD
Quinidine—Urticaria—Prednisone—multiple sclerosis	0.000105	0.000668	CcSEcCtD
Quinidine—Headache—Triamcinolone—multiple sclerosis	0.000105	0.000667	CcSEcCtD
Quinidine—Headache—Methylprednisolone—multiple sclerosis	0.000104	0.000665	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—multiple sclerosis	0.000104	0.000665	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—multiple sclerosis	0.000104	0.000665	CcSEcCtD
Quinidine—Diarrhoea—Betamethasone—multiple sclerosis	0.000104	0.000661	CcSEcCtD
Quinidine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000104	0.000661	CcSEcCtD
Quinidine—Hypotension—Methotrexate—multiple sclerosis	0.000103	0.000657	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000101	0.00064	CcSEcCtD
Quinidine—Dizziness—Dexamethasone—multiple sclerosis	0.0001	0.000639	CcSEcCtD
Quinidine—Dizziness—Betamethasone—multiple sclerosis	0.0001	0.000639	CcSEcCtD
Quinidine—Nausea—Triamcinolone—multiple sclerosis	9.93e-05	0.000632	CcSEcCtD
Quinidine—Nausea—Methylprednisolone—multiple sclerosis	9.9e-05	0.000631	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—multiple sclerosis	9.84e-05	0.000627	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—multiple sclerosis	9.73e-05	0.00062	CcSEcCtD
Quinidine—Vomiting—Betamethasone—multiple sclerosis	9.64e-05	0.000614	CcSEcCtD
Quinidine—Vomiting—Dexamethasone—multiple sclerosis	9.64e-05	0.000614	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—multiple sclerosis	9.59e-05	0.000611	CcSEcCtD
Quinidine—Rash—Dexamethasone—multiple sclerosis	9.56e-05	0.000609	CcSEcCtD
Quinidine—Rash—Betamethasone—multiple sclerosis	9.56e-05	0.000609	CcSEcCtD
Quinidine—Dermatitis—Betamethasone—multiple sclerosis	9.55e-05	0.000608	CcSEcCtD
Quinidine—Dermatitis—Dexamethasone—multiple sclerosis	9.55e-05	0.000608	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.53e-05	0.000607	CcSEcCtD
Quinidine—Headache—Dexamethasone—multiple sclerosis	9.5e-05	0.000605	CcSEcCtD
Quinidine—Headache—Betamethasone—multiple sclerosis	9.5e-05	0.000605	CcSEcCtD
Quinidine—Asthenia—Prednisone—multiple sclerosis	9.47e-05	0.000603	CcSEcCtD
Quinidine—Pruritus—Prednisone—multiple sclerosis	9.34e-05	0.000595	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—multiple sclerosis	9.09e-05	0.000579	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—multiple sclerosis	9.03e-05	0.000576	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.02e-05	0.000575	CcSEcCtD
Quinidine—Nausea—Dexamethasone—multiple sclerosis	9.01e-05	0.000574	CcSEcCtD
Quinidine—Nausea—Betamethasone—multiple sclerosis	9.01e-05	0.000574	CcSEcCtD
Quinidine—Urticaria—Methotrexate—multiple sclerosis	8.77e-05	0.000558	CcSEcCtD
Quinidine—Dizziness—Prednisone—multiple sclerosis	8.73e-05	0.000556	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—multiple sclerosis	8.72e-05	0.000556	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—multiple sclerosis	8.72e-05	0.000556	CcSEcCtD
Quinidine—Vomiting—Prednisone—multiple sclerosis	8.4e-05	0.000535	CcSEcCtD
Quinidine—Rash—Prednisone—multiple sclerosis	8.33e-05	0.00053	CcSEcCtD
Quinidine—Dermatitis—Prednisone—multiple sclerosis	8.32e-05	0.00053	CcSEcCtD
Quinidine—Headache—Prednisone—multiple sclerosis	8.27e-05	0.000527	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—multiple sclerosis	8.13e-05	0.000518	CcSEcCtD
Quinidine—Asthenia—Methotrexate—multiple sclerosis	7.92e-05	0.000504	CcSEcCtD
Quinidine—Nausea—Prednisone—multiple sclerosis	7.84e-05	0.0005	CcSEcCtD
Quinidine—Pruritus—Methotrexate—multiple sclerosis	7.81e-05	0.000497	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—multiple sclerosis	7.55e-05	0.000481	CcSEcCtD
Quinidine—Dizziness—Methotrexate—multiple sclerosis	7.3e-05	0.000465	CcSEcCtD
Quinidine—Vomiting—Methotrexate—multiple sclerosis	7.02e-05	0.000447	CcSEcCtD
Quinidine—Rash—Methotrexate—multiple sclerosis	6.96e-05	0.000443	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—multiple sclerosis	6.95e-05	0.000443	CcSEcCtD
Quinidine—Headache—Methotrexate—multiple sclerosis	6.91e-05	0.00044	CcSEcCtD
Quinidine—Nausea—Methotrexate—multiple sclerosis	6.55e-05	0.000418	CcSEcCtD
Quinidine—SCN2A—Axon guidance—IL6—multiple sclerosis	2.75e-05	0.00032	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.74e-05	0.000319	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	2.74e-05	0.000318	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	2.74e-05	0.000318	CbGpPWpGaD
Quinidine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.73e-05	0.000317	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TYK2—multiple sclerosis	2.72e-05	0.000316	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—TGFB1—multiple sclerosis	2.71e-05	0.000315	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—STAT3—multiple sclerosis	2.71e-05	0.000315	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.71e-05	0.000315	CbGpPWpGaD
Quinidine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.7e-05	0.000314	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—MAPK1—multiple sclerosis	2.66e-05	0.000309	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—IL6—multiple sclerosis	2.65e-05	0.000308	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—MAPK1—multiple sclerosis	2.65e-05	0.000308	CbGpPWpGaD
Quinidine—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.63e-05	0.000306	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—TGFB1—multiple sclerosis	2.6e-05	0.000303	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—MAPK1—multiple sclerosis	2.55e-05	0.000297	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—SRM—multiple sclerosis	2.54e-05	0.000295	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—TNF—multiple sclerosis	2.53e-05	0.000294	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.53e-05	0.000294	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.53e-05	0.000294	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	2.51e-05	0.000292	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	2.51e-05	0.000292	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.48e-05	0.000289	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—RRM1—multiple sclerosis	2.48e-05	0.000288	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	2.46e-05	0.000286	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.46e-05	0.000286	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	2.46e-05	0.000286	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.46e-05	0.000286	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—TNF—multiple sclerosis	2.43e-05	0.000283	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—MAPK1—multiple sclerosis	2.43e-05	0.000282	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.42e-05	0.000282	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.42e-05	0.000282	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.39e-05	0.000278	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.37e-05	0.000276	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.37e-05	0.000276	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SRM—multiple sclerosis	2.37e-05	0.000276	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.36e-05	0.000274	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—TNF—multiple sclerosis	2.34e-05	0.000273	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	2.33e-05	0.000271	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.31e-05	0.000269	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.3e-05	0.000268	CbGpPWpGaD
Quinidine—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.28e-05	0.000265	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.27e-05	0.000264	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.24e-05	0.00026	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.24e-05	0.00026	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.22e-05	0.000259	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.22e-05	0.000258	CbGpPWpGaD
Quinidine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.22e-05	0.000258	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	2.22e-05	0.000258	CbGpPWpGaD
Quinidine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.2e-05	0.000255	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	2.19e-05	0.000255	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.19e-05	0.000254	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—BCHE—multiple sclerosis	2.18e-05	0.000253	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.17e-05	0.000253	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.17e-05	0.000253	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.16e-05	0.000251	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—MMP9—multiple sclerosis	2.14e-05	0.000249	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.14e-05	0.000249	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	2.13e-05	0.000248	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.11e-05	0.000245	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.1e-05	0.000244	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	2.07e-05	0.00024	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.06e-05	0.000239	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.05e-05	0.000239	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.05e-05	0.000239	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GPC5—multiple sclerosis	2.05e-05	0.000238	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—IL6—multiple sclerosis	2.04e-05	0.000237	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SRM—multiple sclerosis	2.03e-05	0.000236	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.01e-05	0.000234	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.01e-05	0.000233	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	2e-05	0.000232	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—IL6—multiple sclerosis	1.96e-05	0.000228	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	1.95e-05	0.000227	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	1.94e-05	0.000226	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.92e-05	0.000224	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—STAT3—multiple sclerosis	1.9e-05	0.000221	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—IL6—multiple sclerosis	1.89e-05	0.00022	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	1.88e-05	0.000218	CbGpPWpGaD
Quinidine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.88e-05	0.000218	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.88e-05	0.000218	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	1.87e-05	0.000217	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—IL6—multiple sclerosis	1.86e-05	0.000217	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.84e-05	0.000214	CbGpPWpGaD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.83e-05	0.000213	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.82e-05	0.000211	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	1.81e-05	0.000211	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.8e-05	0.00021	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.8e-05	0.000209	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	1.79e-05	0.000208	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.79e-05	0.000208	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.79e-05	0.000208	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	1.77e-05	0.000206	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	1.76e-05	0.000205	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	1.76e-05	0.000205	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	1.73e-05	0.000201	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	1.73e-05	0.000201	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.72e-05	0.000201	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—RRM1—multiple sclerosis	1.7e-05	0.000197	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	1.69e-05	0.000197	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.69e-05	0.000196	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.69e-05	0.000196	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.67e-05	0.000194	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.67e-05	0.000194	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.67e-05	0.000194	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	1.65e-05	0.000192	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TNF—multiple sclerosis	1.65e-05	0.000192	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.64e-05	0.000191	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.64e-05	0.00019	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.63e-05	0.00019	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	1.63e-05	0.000189	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	1.62e-05	0.000188	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	1.62e-05	0.000188	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.61e-05	0.000188	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.56e-05	0.000182	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.56e-05	0.000182	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.56e-05	0.000181	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000181	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.54e-05	0.000179	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.54e-05	0.000179	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.53e-05	0.000178	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	1.47e-05	0.00017	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.45e-05	0.000168	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.43e-05	0.000167	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.43e-05	0.000166	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.43e-05	0.000166	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.43e-05	0.000166	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—BCHE—multiple sclerosis	1.42e-05	0.000166	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.4e-05	0.000162	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	1.39e-05	0.000162	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.36e-05	0.000158	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.34e-05	0.000155	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—IL6—multiple sclerosis	1.33e-05	0.000155	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.000154	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.32e-05	0.000153	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000152	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.31e-05	0.000152	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.28e-05	0.000148	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.27e-05	0.000147	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	1.26e-05	0.000147	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	1.25e-05	0.000146	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.25e-05	0.000145	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.25e-05	0.000145	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.23e-05	0.000143	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.22e-05	0.000142	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.21e-05	0.00014	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.16e-05	0.000135	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.15e-05	0.000134	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.14e-05	0.000132	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.13e-05	0.000131	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—POMC—multiple sclerosis	1.13e-05	0.000131	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.12e-05	0.00013	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.11e-05	0.000129	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.1e-05	0.000128	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.1e-05	0.000128	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.09e-05	0.000127	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.09e-05	0.000127	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.08e-05	0.000126	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.07e-05	0.000125	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1.06e-05	0.000123	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000123	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	1.04e-05	0.000121	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.04e-05	0.000121	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.03e-05	0.00012	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.03e-05	0.00012	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—ALB—multiple sclerosis	1.03e-05	0.000119	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.01e-05	0.000117	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.82e-06	0.000114	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	9.79e-06	0.000114	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—BCHE—multiple sclerosis	9.75e-06	0.000113	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	9.62e-06	0.000112	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.45e-06	0.00011	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—POMC—multiple sclerosis	9.4e-06	0.000109	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—APOE—multiple sclerosis	9.35e-06	0.000109	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—BCHE—multiple sclerosis	8.93e-06	0.000104	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	8.89e-06	0.000103	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	8.69e-06	0.000101	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	8.66e-06	0.000101	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—APOE—multiple sclerosis	8.58e-06	9.98e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—APOE—multiple sclerosis	8.57e-06	9.97e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—ALB—multiple sclerosis	8.57e-06	9.96e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.44e-06	9.81e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.39e-06	9.76e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.35e-06	9.71e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—POMC—multiple sclerosis	8.04e-06	9.34e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—APOE—multiple sclerosis	7.99e-06	9.29e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	7.9e-06	9.18e-05	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.83e-06	9.1e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—BCHE—multiple sclerosis	7.78e-06	9.05e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.69e-06	8.94e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	7.57e-06	8.81e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	7.46e-06	8.67e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—POMC—multiple sclerosis	7.37e-06	8.57e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—POMC—multiple sclerosis	7.36e-06	8.56e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.33e-06	8.53e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—ALB—multiple sclerosis	7.33e-06	8.52e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.27e-06	8.45e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	7.23e-06	8.41e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.21e-06	8.38e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	6.9e-06	8.03e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—POMC—multiple sclerosis	6.86e-06	7.98e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—ALB—multiple sclerosis	6.72e-06	7.82e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	6.72e-06	7.81e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ALB—multiple sclerosis	6.71e-06	7.81e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	6.62e-06	7.7e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.57e-06	7.64e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	6.57e-06	7.64e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—APOE—multiple sclerosis	6.35e-06	7.38e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ALB—multiple sclerosis	6.26e-06	7.27e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—APOE—multiple sclerosis	6.22e-06	7.23e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.21e-06	7.22e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	6.11e-06	7.1e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—APOE—multiple sclerosis	5.86e-06	6.82e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	5.52e-06	6.42e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—POMC—multiple sclerosis	5.45e-06	6.34e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—APOE—multiple sclerosis	5.37e-06	6.25e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—POMC—multiple sclerosis	5.34e-06	6.21e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	5.25e-06	6.1e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	5.14e-06	5.97e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—POMC—multiple sclerosis	5.04e-06	5.86e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.03e-06	5.84e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ALB—multiple sclerosis	4.97e-06	5.78e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ALB—multiple sclerosis	4.87e-06	5.66e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.8e-06	5.58e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—APOE—multiple sclerosis	4.68e-06	5.44e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	4.66e-06	5.42e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—POMC—multiple sclerosis	4.62e-06	5.37e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ALB—multiple sclerosis	4.59e-06	5.34e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—APOE—multiple sclerosis	4.41e-06	5.13e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—APOE—multiple sclerosis	4.37e-06	5.09e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ALB—multiple sclerosis	4.21e-06	4.89e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—POMC—multiple sclerosis	4.02e-06	4.68e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	3.88e-06	4.51e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	3.86e-06	4.49e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—POMC—multiple sclerosis	3.79e-06	4.41e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—POMC—multiple sclerosis	3.76e-06	4.37e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOE—multiple sclerosis	3.74e-06	4.35e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	3.67e-06	4.27e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ALB—multiple sclerosis	3.67e-06	4.26e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ALB—multiple sclerosis	3.46e-06	4.02e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ALB—multiple sclerosis	3.43e-06	3.98e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.27e-06	3.8e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—POMC—multiple sclerosis	3.21e-06	3.73e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.03e-06	3.53e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.03e-06	3.52e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	2.97e-06	3.45e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ALB—multiple sclerosis	2.93e-06	3.4e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.88e-06	3.35e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.48e-06	2.88e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.28e-06	2.65e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.26e-06	2.63e-05	CbGpPWpGaD
